166 related articles for article (PubMed ID: 38446235)
1. Perioperative management and clinical outcomes of peristomal pyoderma gangrenosum.
Becker SL; Rios-Duarte JA; Morrison GM; Xia E; Mostaghimi A; Himed S; Kaffenberger BH; Zhang D; Shields BE; Cogen AL; Ortega-Loayza AG
Arch Dermatol Res; 2024 Mar; 316(4):98. PubMed ID: 38446235
[TBL] [Abstract][Full Text] [Related]
2. Management of peristomal pyoderma gangrenosum.
Kiran RP; O'Brien-Ermlich B; Achkar JP; Fazio VW; Delaney CP
Dis Colon Rectum; 2005 Jul; 48(7):1397-403. PubMed ID: 15868233
[TBL] [Abstract][Full Text] [Related]
3. Clinical features, causes, treatments, and outcomes of peristomal pyoderma gangrenosum (PPG) in 44 patients: The Mayo Clinic experience, 1996 through 2013.
Barbosa NS; Tolkachjov SN; El-Azhary RA; Davis MD; Camilleri MJ; McEvoy MT; Bridges AG; Wetter DA
J Am Acad Dermatol; 2016 Nov; 75(5):931-939. PubMed ID: 27473454
[TBL] [Abstract][Full Text] [Related]
4. Early diagnosis and early corticosteroid administration improves healing of peristomal pyoderma gangrenosum in inflammatory bowel disease.
Funayama Y; Kumagai E; Takahashi K; Fukushima K; Sasaki I
Dis Colon Rectum; 2009 Feb; 52(2):311-4. PubMed ID: 19279428
[TBL] [Abstract][Full Text] [Related]
5. Postoperative and Peristomal Pyoderma Gangrenosum: Subtypes of Pyoderma Gangrenosum.
Kipers T; Tolkachjov SN
Dermatol Clin; 2024 Apr; 42(2):171-181. PubMed ID: 38423679
[TBL] [Abstract][Full Text] [Related]
6. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients.
Farhi D; Cosnes J; Zizi N; Chosidow O; Seksik P; Beaugerie L; Aractingi S; Khosrotehrani K
Medicine (Baltimore); 2008 Sep; 87(5):281-293. PubMed ID: 18794711
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of peristomal pyoderma gangrenosum: A systematic review.
Afifi L; Sanchez IM; Wallace MM; Braswell SF; Ortega-Loayza AG; Shinkai K
J Am Acad Dermatol; 2018 Jun; 78(6):1195-1204.e1. PubMed ID: 29288099
[TBL] [Abstract][Full Text] [Related]
8. Twenty cases of peristomal pyoderma gangrenosum: diagnostic implications and management.
Sheldon DG; Sawchuk LL; Kozarek RA; Thirlby RC
Arch Surg; 2000 May; 135(5):564-8; discussion 568-9. PubMed ID: 10807281
[TBL] [Abstract][Full Text] [Related]
9. Caring for the patient with peristomal pyoderma gangrenosum.
Stamm L; Swatske ME; Hickey S; Shephrd Z; Dalgaard J
J Wound Ostomy Continence Nurs; 1995 Sep; 22(5):237-41. PubMed ID: 7550780
[TBL] [Abstract][Full Text] [Related]
10. Peristomal pyoderma gangrenosum: 12-year experience in a single tertiary referral centre.
Toh JWT; Young CJ; Rickard MJFX; Keshava A; Stewart P; Whiteley I
ANZ J Surg; 2018 Oct; 88(10):E693-E697. PubMed ID: 29984478
[TBL] [Abstract][Full Text] [Related]
11. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
[TBL] [Abstract][Full Text] [Related]
12. Perioperative management of pyoderma gangrenosum.
Haag CK; Bacik L; Latour E; Morse DC; Fett NM; Ortega-Loayza AG
J Am Acad Dermatol; 2020 Aug; 83(2):369-374. PubMed ID: 31927079
[TBL] [Abstract][Full Text] [Related]
13. Management of peristomal pyoderma gangrenosum.
Poritz LS; Lebo MA; Bobb AD; Ardell CM; Koltun WA
J Am Coll Surg; 2008 Feb; 206(2):311-5. PubMed ID: 18222385
[TBL] [Abstract][Full Text] [Related]
14. Pyoderma gangrenosum at multiple sites in a post-colostomy ulcerative colitis patient with chronic hepatitis B virus: A case report.
Wang B; Liu T; Liu F; He YL
Int Wound J; 2020 Feb; 17(1):187-190. PubMed ID: 31663272
[TBL] [Abstract][Full Text] [Related]
15. Surgical management of extensive peristomal pyoderma gangrenosum associated with colon cancer.
Ishikawa K; Minamimoto T; Mizuki T; Furukawa H
J Wound Ostomy Continence Nurs; 2015; 42(1):102-5. PubMed ID: 25549316
[TBL] [Abstract][Full Text] [Related]
16. Severe peristomal pyoderma gangrenosum: a case study.
Brady E
J Wound Ostomy Continence Nurs; 1999 Nov; 26(6):306-11. PubMed ID: 10865615
[TBL] [Abstract][Full Text] [Related]
17. A novel topical therapy for resistant and early peristomal pyoderma gangrenosum.
Pearson WA; Prentice DA; Sinclair DL; Lim LY; Carville KJ
Int Wound J; 2019 Oct; 16(5):1136-1143. PubMed ID: 31298491
[TBL] [Abstract][Full Text] [Related]
18. A Case Series of 4 Patients With Peristomal Pyoderma Gangrenosum: Review of Risk Factors and Treatment Response.
Turrión-Merino L; Hermosa-Zarza E; Miguel L; Muñoz-Zato E
Actas Dermosifiliogr; 2016 Apr; 107(3):e13-7. PubMed ID: 26626501
[TBL] [Abstract][Full Text] [Related]
19. Clinical treatment options for peristomal pyoderma gangrenosum.
Vujnovich A
Br J Nurs; 2005 Sep 8-21; 14(16):S4-8. PubMed ID: 16215501
[TBL] [Abstract][Full Text] [Related]
20. Peristomal pyoderma gangrenosum and inflammatory bowel disease.
Cairns BA; Herbst CA; Sartor BR; Briggaman RA; Koruda MJ
Arch Surg; 1994 Jul; 129(7):769-72. PubMed ID: 7912923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
